Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution.

Children Focal areas of signal intensity Genotype Neurofibromatosis type 1 Neurological manifestations Phenotype

Journal

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 07 11 2022
revised: 05 02 2023
accepted: 26 02 2023
medline: 11 4 2023
pubmed: 12 3 2023
entrez: 11 3 2023
Statut: ppublish

Résumé

Neurofibromatosis type 1 (NF1) is a phenotypically heterogenous multisystem cancer predisposition syndrome manifesting in childhood and adolescents. Central nervous system (CNS) manifestations include structural, neurodevelopmental, and neoplastic disease. We aimed to (1) characterize the spectrum of CNS manifestations of NF1 in a paediatric population, (2) explore radiological features in the CNS by image analyses, and (3) correlate genotype with phenotypic expression for those with a genetic diagnosis. We performed a database search in the hospital information system covering the period between January 2017 and December 2020. We evaluated the phenotype by retrospective chart review and imaging analysis. 59 patients were diagnosed with NF1 [median age 10.6 years (range, 1.1-22.6); 31 female] at last follow-up, pathogenic NF1 variants were identified in 26/29. 49/59 patients presented with neurological manifestations including 28 with structural and neurodevelopmental findings, 16 with neurodevelopmental, and 5 with structural findings only. Focal areas of signal intensity (FASI) were identified in 29/39, cerebrovascular anomalies in 4/39. Neurodevelopmental delay was reported in 27/59 patients, learning difficulties in 19/59. Optic pathway gliomas (OPG) were diagnosed in 18/59 patients, 13/59 had low-grade gliomas outside the visual pathways. 12 patients received chemotherapy. Beside the established NF1 microdeletion, neither genotype nor FASI were associated with the neurological phenotype. NF1 was associated with a spectrum of CNS manifestations in at least 83.0% of patients. Regular neuropsychological assessment complementing frequent clinical and ophthalmologic testing for OPG is necessary in the care of each child with NF1.

Identifiants

pubmed: 36905830
pii: S1090-3798(23)00030-2
doi: 10.1016/j.ejpn.2023.02.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-61

Informations de copyright

© 2023 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Daniela Angelova-Toshkina (D)

Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: daniela.angelova-toshkina@uk-augsburg.de.

Josua A Decker (JA)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Medical Centre, Stenglinstraße 2, 86156, Augsburg, Germany. Electronic address: josua.decker@uk-augsburg.de.

Thomas Traunwieser (T)

Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: thomas.traunwieser@uk-augsburg.de.

Johannes Holzapfel (J)

Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: johannes.holzapfel@uk-augsburg.de.

Stefanie Bette (S)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Medical Centre, Stenglinstraße 2, 86156, Augsburg, Germany. Electronic address: stefanie.bette@uk-augsburg.de.

Simon Huber (S)

Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: simon.huber@uk-augsburg.de.

Mareike Schimmel (M)

Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: mareike.schimmel@uk-augsburg.de.

Kurt Vollert (K)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Medical Centre, Stenglinstraße 2, 86156, Augsburg, Germany. Electronic address: kurt.vollert@uk-augsburg.de.

Brigitte Bison (B)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: brigitte.bison@uk-augsburg.de.

Thomas Kröncke (T)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Medical Centre, Stenglinstraße 2, 86156, Augsburg, Germany. Electronic address: thomas.kroencke@uk-augsburg.de.

Nuria C Bramswig (NC)

Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40255, Düsseldorf, Germany. Electronic address: nuria.braemswig@hhu.de.

Dagmar Wieczorek (D)

Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40255, Düsseldorf, Germany. Electronic address: dagmar.wieczorek@med.uni-duesseldorf.de.

Astrid K Gnekow (AK)

Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: astrid.gnekow@uk-augsburg.de.

Michael C Frühwald (MC)

Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: michael.fruehwald@uk-augsburg.de.

Michaela Kuhlen (M)

Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: michaela.kuhlen@uk-augsburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH